Finished
Lymph Node Mapping in Patients With Endometrial Cancer
NCT01818739 · Ohio State University Comprehensive Cancer Center · Updated 22 March 2023
- What is being tested
- sentinel lymph node detection; indocyanine green solution; isosulfan blue; sentinel lymph node biopsy
- For
- Endometrial Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 85 years. About 204 people. The full rules are on the registry page.
- Where
- United States (2 sites)
- When
- Starts or started March 2013, ends 31 March 2017. Registered 26 March 2013.
- Results
- Posted on the registry on 22 June 2021.
In the researchers' words
This clinical trial studies lymph node mapping in patients with endometrial cancer. Lymph node mapping may allow for limited removal of lymph nodes in as part of endometrial cancer staging and treatment.
Sites
- Smilow Cancer Hospital at Yale New HavenNew Haven, Connecticut, United States
- Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical CenterColumbus, Ohio, United States